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Abstract: Okadaic acid (OA) and its analogues, dinophysistoxin 1 (DTX1) and 
dinophysistoxin 2 (DTX2), are lipophilic and heat-stable marine toxins produced by 
dinoflagellates, which can accumulate in filter-feeding bivalves. These toxins cause 
diarrheic shellfish poisoning (DSP) in humans shortly after the ingestion of contaminated 
seafood. Studies carried out in mice indicated that DSP poisonous are toxic towards 
experimental animals with a lethal oral dose 2–10 times higher than the intraperitoneal (i.p.) 
lethal dose. The focus of this work was to study the absorption of OA, DTX1 and DTX2 
through the human gut barrier using differentiated Caco-2 cells. Furthermore, we compared 
cytotoxicity parameters. Our data revealed that cellular viability was not compromised by 
toxin concentrations up to 1 μM for 72 h. Okadaic acid and DTX2 induced no significant 
damage; nevertheless, DTX1 was able to disrupt the integrity of Caco-2 monolayers at 
concentrations above 50 nM. In addition, confocal microscopy imaging confirmed that the 
tight-junction protein, occludin, was affected by DTX1. Permeability assays revealed that 
only DTX1 was able to significantly cross the intestinal epithelium at concentrations above 
100 nM. These data suggest a higher oral toxicity of DTX1 compared to OA and DTX2. 
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1. Introduction 
During harmful algae blooms, bivalves accumulate marine toxins, being a serious threat for human 
consumers of edible shellfish. Toxins causing diarrhetic shellfish poisoning (DSP) are produced by 
several marine dinoflagellates of the genera, Prorocentrum and Dinophysis, which are of worldwide 
distribution [1]. DSP is characterized by diarrhea, gastrointestinal distress, nausea, vomiting and, 
frequently, abdominal pain. These symptoms usually appear from 30 min to 12 h after ingestion of 
contaminated seafood [2]. However, as of now, there have been no records of human fatalities related 
to acute DSP intoxication [3]. Toxins causing DSP were first reported by Yasumoto et al., in 1978 [2]. 
These toxins are lipophilic and heat-stable polyether compounds that can be accumulated in the 
hepatopancreas of filter-feeding bivalve species, such as oysters, clams, scallops or mussels [4,5]. The 
main compound is okadaic acid (OA); it was first isolated from the marine sponge,  
Halichondria okadai, and its structure (Figure 1) was studied in 1981 by Tachibana et al., [6]. Other 
DSP toxins are the isomeric compound, dinophysistoxin-2 (DTX2), the methylated derivative, 
dinophysistoxin-1 (DTX1), and the toxins acylated at the C-7 hydroxyl group with long-chain fatty 
acids, collectively known as dinophysistoxin-3 (DTX3) [3,7–10].  
Figure 1. Chemical structure of (A) okadaic acid (OA); (B) dinophysistoxin-1 (DTX1); and (C) DTX2. 
 




The mechanism of action of this group of toxins is mainly the potent inhibition of serine/threonine 
protein phosphatases 1 (PP1) and 2A (PP2A) [11–14]. The different inhibitory potencies of DSP toxins 
on protein phosphatases have been determined allowing the establishment of inhibition equivalency 
factors (IEFs). The IEFs were calculated as the ratio of the IC50 for OA to the IC50 for DTX1 or DTX2. 
The IEF of DTX1 for PP1 is in the 0.4–0.9 range, whereas for PP2A, it is between 0.9 and 2.4 [15–18], 
indicating more inhibition of this phosphatase than that exerted by OA. Regarding DTX2, the IEF for 
PP2A is lower, with reported values ranging from 0.4 to 0.6 [18,19]. According to the current studies, 
the rest of the derivatives have even less inhibition effect over both phosphatases [15,20–23]. 
In the present work, we have studied and compared some cytotoxicity parameters of OA, DTX1 and 
DTX2. Our final goal was to determine the toxin absorption through the human intestine by using 
human colon adenocarcinoma (Caco-2) cells.  
2. Results 
2.1. Cytotoxic Effect of OA, DTX1 and DTX2 in Differentiated Caco-2 Monolayers 
Metabolic activity assay: Cytotoxic effects of OA, DTX1 and DTX2 (1, 10, 20, 40, 100, 200, 500 
and 1000 nM) in differentiated Caco-2 cells have been evaluated in a time-dependent manner by the 
AlamarBlue metabolic activity assay. Incubation with 0.01% Triton X-100 has been used as a positive 
control of death. Data are shown in Figure 2 as the percent of fluorescence vs. control. Differentiated 
Caco-2 cells treated with OA, DTX1 or DTX2 did not show any decrease in fluorescence intensity 
(Figure 2A–C). Therefore, none of the toxins affect the cell metabolism significantly, even at the 
highest concentration and incubation time tested (1000 nM for 72 h), indicating no change in  
cell viability.  
Cell membrane integrity assay: Some fluorescent methods allow a non-destructive evaluation of 
apoptosis by detecting changes in the structure of cell membranes. Annexin V has a high affinity for 
phosphatidylserine (PS), a phospholipid component located on the inner surface of the lipid bilayer of 
the cellular plasma membrane. During early apoptosis processes, this PS migrates to the outer portion, 
becomes exposed on the surface of the cell and can be detected by binding to annexin V labeled with a 
fluorescent dye. The annexin V assay was carried out in differentiated Caco-2 monolayers that were 
treated for 24 h with 100 nM of OA, DTX1, DTX2 or vehicle. Incubation with 0.005% Triton X-100 was 
used as a positive control of cell death and 1 μM staurosporine (STP) and 100 mM sodium butyrate 
(NaBT) as inductors of cell apoptosis.  
Control confocal microscopy images (Figure 3A) showed normal Caco-2 monolayers with no 
fluorescent signal, as expected. Lack of fluorescence is also found in cells incubated with OA, DTX1 
and DTX2 (Figure 3B–D), revealing that no apoptotic processes were undergoing on the Caco-2 
monolayers under these conditions. As for the apoptosis inductor treatments, cells incubated with  
1 μM STP and 100 mM NaBT (Figure 3E,F) showed evident FITC green fluorescence zones, 
indicating structural changes in the plasma membrane integrity. The treatment with 0.005% Triton X-100 
(Figure 3G) showed a heavily damaged cell monolayer with noticeable loss of substrate adhesion and 
fluorescent green dots corresponding to the FITC-marked annexin V. 




Figure 2. Viability of Caco-2 cells treated with OA, DTX1 and DTX2. Differentiated 
Caco-2 cells were incubated with increasing concentrations of (A) OA, (B) DTX1 and  
(C) DTX2 for 6, 8, 10, 12, 24, 48 and 72 h. 0.01% Triton X-100 treatment is also 
represented (D). Results are expressed as the percent of viability vs. control. Reported 
values are the mean ± SEM of three independent experiments performed in duplicate.  
 
 
2.2. Effect of OA, DTX1 and DTX2 on the Trans-Epithelial Electrical Resistance (TEER) of 
Differentiated Caco-2 Monolayers 
We assessed tight junction formation stability through measurements of trans-epithelial electrical 
resistance (TEER). Therefore, only inserts with TEER higher than 300 Ωcm
2
, which indicates that the 
Caco-2 monolayer is intact and suitable for drug permeability assays [24], were used for further 
testing. We studied the changes that OA, DTX1 and DTX2 induced in the TEER of the Caco-2 
monolayer as a function of time. Differentiated Caco-2 monolayers were incubated with 10, 50 and  
100 nM OA, DTX1 and DTX2. TEER was measured immediately before the toxins addition and after 3, 
6, 12 and 24 h of incubation with them. OA and DTX2 did not induce any change in the TEER values of 
Caco-2 monolayers at any concentration or time tested (Figure 4). However, 50 nM DTX1 (Figure 4E) 
significantly decreased the TEER value when incubated for 24 h. This decrease was much more 
noticeable at 100 nM for 12 and 24 h (Figure 4H), indicating a clear disturbance on the Caco-2 monolayer. 




Figure 3. Confocal imaging of differentiated Caco-2 monolayers treated with OA, DTX1 
and DTX2 and labeled with FITC-conjugated annexin V (left columns). Transmission 
images of the same cells are presented in the right columns. (A) shows control cells; while 
(B–G) are photographs from Caco-2 monolayers incubated for 24 h with 100 nM OA, 100 
nM DTX1, 100 nM DTX2, 1 μM staurosporine, 100 mM sodium butyrate and 0.005% 
Triton X-1000, respectively. The images are representative of three independent 
experiments. Image magnification is 40×. The scale bar is 25 μm. 
 




Figure 4. Effects of OA, DTX1 and DTX2 on the trans-epithelial electric resistance 
(TEER) of differentiated Caco-2 monolayers. Figure shows the TEER ratio between  
toxin-treated monolayers and control monolayers. (A,D,G) Monolayers incubated with 10, 
50 and 100 nM OA; (B,E,H) 10, 50 and 100 nM DTX1; and (C,F,I) 10, 50 and  
100 nM DTX2. (*) Indicates statistically different value (p < 0.05) versus time 0 h. 
Reported values are the mean ± SEM of three independent experiments performed  
in duplicate. 
 
2.3. Confocal Microscopy Imaging for Visualizing Occludin in Caco-2 Cells Treated with OA, DTX1 
and DTX2 
The observed decrease of TEER in the Caco-2 cells when incubated with 50 nM DTX1 for more than 
12 hours suggests some damage to the monolayer that has been often linked to tight-junction disruption. 
Tight-junction strands are composed of membrane integral proteins, occludin being the best-studied 
member. We evaluate the integrity of such tight-junctions in Caco-2 cells treated with 100 nM OA, 
DTX1 and DTX2 for 24 h by labeling occludin. Immunofluorescent staining in control conditions 
(Figure 5A) showed occludin located mainly at the cell border. Neither 100 nM OA nor 100 nM DTX2 
treatments (Figure 5B,D) had a significant effect on occludin location. However, Caco-2 cells 
incubated with 100 nM DTX1 presented fragmented and less uniform staining of occludin that even 
forms small vesicles at some points and showed marked indentations between adjacent cells. (Figure 5C). 




Treatment with 0.005% Triton X-100, 100 mM NaBT and 1 μM STP also for 24 h, which disrupted 
the barrier function, resulted in a redistribution of occludin with adjacent diffuse intracellular staining 
and a granular appearance (Figure 5E–G). 
Figure 5. Effects of OA, DTX1 and DTX2 on occludin distribution in differentiated Caco-2 
monolayers. Occludin from Caco-2 monolayers were labeled with anti-occludin, mouse 
monoclonal antibody (Alexa Fluor
®
 488). (A) Control monolayers and monolayers 
incubated with (B) 100 nM OA; (C) 100 nM DTX1; (D) 100 nM DTX2; (E) 1 μM 
staurosporine; (F) 100 mM sodium butyrate; and (G) 0.005% Triton X-1000 for 24 h. 
Representative images of three independent experiments. Image magnification is 40×. The 
scale bar is 25 μm. 
 
2.4. Permeability of Caco-2 Monolayers to OA, DTX1 and DTX2 
With the aim of evaluating the transport of OA, DTX1 and DTX2 through the cell monolayer, we 
performed the permeability assays as described in Section 4.7. Caco-2 cell monolayers were incubated 
with OA, DTX1 and DTX2 for 3, 6, 12 and 24 h. Figure 6 shows the amount of toxin quantified in 




samples taken from the apical (insert) and basolateral (well) side of the monolayer. According to the 
results, almost all the OA and DTX2 remain in the apical side (Figure 6 A,D and C,F). Thus, the toxins 
were unable to cross the Caco-2 monolayer under the experimental conditions used. Despite this, 
Caco-2 monolayers incubated with 100 nM DTX1 showed an increase in the amount of toxin in the 
basolateral side after 24 h of incubation (Figure 6E). DTX1 showed the highest permeability 
concurrent with the highest decrease in transepithelial electrical resistance (TEER) (Figure 4H). 
Likewise, in the absence of a cell monolayer (shown as no cells in Figure 6), all the toxins easily flow 
over inserts. 
Figure 6. Permeability of differentiated Caco-2 monolayers to OA, DTX1 and DTX2. 
Toxin content in samples taken from wells and inserts with or without Caco-2 monolayers 
was quantified. The cells were incubated with 50 and 100 nM of (A,D) OA; (B,E) DTX1; 
and (C,F) DTX2. White bars show the amount of toxin in the well/receiver compartments, 
while black bars represent the toxin found in the inserts/donor compartments. The grey 
bars indicate the amount of toxin initially used in the treatments. Reported values are the 
mean ± SEM of three independent experiments performed in duplicate.  
 
3. Discussion 
At present, the Caco-2 cell line is one of the best available models of human enterocytes in vitro, 
which may represent in vivo intestinal epithelium well [25]. Despite their tumoral origin, these cells are 
able to spontaneously differentiate to small intestine enterocytes after 21 days of culture, expressing, 
for instance, the brush border enzyme activities [26]. In the present study, we have evaluated the 
cytotoxic responses of differentiated Caco-2 cells to OA and compared to the cytotoxicity of DTX1 




and DTX2. OA cytotoxicity was not detected in the viability assays (Figure 2), in agreement with the 
data of Tripuraneni et al. [27] and Ehlers et al. [28]. In addition, our data are in accordance with  
Okada et al. [29], who detected no cell membrane damage nor LHD release with 1–2 μM OA. On the 
other hand, treatments with DTX1 and DTX2 up to 1 μM for 72 h did not show noticeable cytotoxic 
effects on differentiated Caco-2 cells. Moreover, we observed no significant apoptotic induction on 
cells treated with 100 nM OA, DTX1 and DTX2 for 24 h (Figure 3).  
When Caco-2 cells are cultured on inserts, they display the typical properties of an epithelial 
barrier, allowing for studies of permeability [30]. In these studies, TEER is a measure of the ionic 
movement across the paracellular pathway that can provide an indirect assessment of tight-junctions 
establishment and stability. Tight-junctions prevent the passage of molecules and ions through the 
spaces between cells. Tripuraneni et al. [27] found that high concentrations of OA (≥600 nM) 
decreased the TEER of Caco-2 monolayers, disrupting the barrier function of intestinal cells and 
increasing paracellular permeability in the absence of any noticeable cytotoxic response. However, 
Ehlers et al. [28] reported a lack of OA effect on the integrity of the monolayer based on the absence 
of TEER changes when differentiated Caco-2 monolayers were treated with up to 200 nM OA for 24h. 
Our results revealed that even though OA and DTX2 did not induce any change (Figure 4A,D,G and 
4C,F,I), 50 nM DTX1 started to decrease TEER values, lowering them to 50% after 12 h treatment 
with 100 nM DTX1 and to 70% after 24 h (Figure 4H). This suggests a clear effect of DTX1 on the 
integrity of Caco-2 monolayers when compared to the same concentrations of OA and DTX2. 
Nevertheless, as we could observe, a decrease in TEER does not necessarily imply cellular toxicity.  
Okada et al. in 2000 [29] also found a significant TEER reduction in Caco-2 cells in just 30 to  
90 min, but with concentrations of 1 to 2 μM of OA and without cell damage or death. Wang et al. 
observed notable damage to the intestinal ultrastructure after oral administration of OA to mice, which 
was repaired within 24 h, which also indicate no cell death [31].  
Thus, one of the possible reasons for the decrease of TEER in DTX1-treated Caco-2 monolayers 
could be the damage of tight-junctions among cells. Tight-junctions form the physical barrier to the 
diffusion of substances through the paracellular space [32]. Their structure consists of assemblies of 
trans-membrane proteins, mainly claudins and occludin [33,34], which are associated with scaffolding 
proteins of the zonula occludens family [35] and signaling proteins, such as protein kinases and 
phosphatases [36,37]. It has also been reported in the involvement of peri-junctional actin and myosin 
light chains in the regulation of the barrier functions of tight-junctions [33,38]. Phosphorylation and 
dephosphorylation processes on components of the tight-junctions, especially on occludin, have a high 
impact on paracellular permeability, where PP2A and PP1 seem to be key enzymes [39–41].  
Seth et al. [39] reported that protein phosphatase inhibitors and reduced expression of PP2A and PP1 
accelerated the calcium-induced increase in transepithelial electrical resistance and the barrier to inulin 
permeability and also enhanced the junctional organization of occludin and ZO-1 during  
tight-junction assembly in Caco-2 cells. In this context and based on our results, apart from the 
previously reported lack of a TEER decrease, we observed no modifications on the distribution of 
occludin when cells were incubated with OA and DTX2 (Figure 5B,D). Permeability assays carried 
out with differentiated Caco-2 cells allow us to know if the toxins are absorbed in the intestinal tract. 
Our results revealed no significant changes of permeability through the monolayer when the Caco-2 
cells were treated with OA or DTX2 up to 100 nM for 24 h (Figure 6A,D and 6C,F). Therefore OA 




and DTX2 are poorly transported from the luminal to the blood side when the Caco-2 monolayer is not 
altered. This is in line with the data generated by Ehlers et al. [28]; their permeability assays revealed 
a very limited passage of OA after 24 h with only 2% of the applied dose found in the basolateral side 
and about 2%–3% trapped into Caco-2 cells. 
However, 100 nM DTX1-treated Caco-2 cells, whose TEER values were highly reduced, showed a 
clear alteration of the occludin labeling, with discontinuous distribution, indentations between adjacent 
cells and noticeable, numerous, rounded vesicles; opposite to the smooth and evenly distributed 
occludin in controls. (Figure 5C). Another possible explanation for TEER reduction could be the 
disruption of the actin cytoskeleton by DTX1, since the cytoskeleton is important for mechanical 
stability and the integrity of epithelial cells and tissues. This effect was already reported in several  
in vitro cell cultures treated with OA [29,42–45]. Some of the main domains of the plasma membrane, 
where actin filaments are concentrated, are substrate adhesion sites [46]. Therefore, the detachment 
from the substrate that DTX1 induces, on some parts of the Caco-2 monolayer (images not shown), is 
likely to be caused by the disruption of the actin cytoskeleton. This effect could also explain the 
reduction of the TEER values and the increase in permeability when the monolayer integrity has  
been compromised.  
The permeability of Caco-2 cells to DTX1 is significantly higher compared to the same 
concentration of OA and DTX2 with almost 50% of the initial amount recovered from the basolateral 
side at 24 h, as shown in Figure 6E. DSP toxins are potent inhibitors of Ser/Thr protein phosphatases, 
especially DTX1 over PP2A, but also OA over PP1 [15–18]. According to this, a 1.6-fold lower 
dissociation constant for DTX1 compared to OA for the catalytic subunit PP2A was reported [15]. 
Furthermore, a lower IC50 value for DTX1 with respect to OA for PP2A resulting in IEFs of 1.6–2.4 
was observed [17,18]. On the contrary, different authors proposed a higher IC50 value for DTX1 
compared to OA for the PP2A, which was translated into an IEF of 0.6–0.9 [47–49]. Several reasons 
could explain the different IEFs reported in the literature (differences in enzyme sources, enzyme 
concentrations, toxin standard purities, enzyme substrates and buffer compositions result in different IC50 
values) [18]. In addition, the ability of DSP toxins to increase paracellular permeability through the 
inhibition of such phosphatases has been recently put into question [10]. In this study, the treatments 
with each toxin were performed in parallel to better establish a comparison between them. Based on 
the different results obtained with DTX1, OA and DTX2, we could suggest a link between the 
observed alteration of permeability with DTX1 and its PP2A inhibitory potency. 
OA is highly toxic to mice by intraperitoneal injection, with reported LD50 values ranging from 192 
to 255 μg/kg b.w. (body weight) for OA [6,19,50,51]. As for the acute toxicity of other DSP toxins, a 
minimum lethal dose of 160 μg/kg for DTX1 [5,52] and 350 μg/kg b.w. for DTX2 [19] was established. 
The oral LD50 may be 2 to 10 fold higher than the i.p. [53]. However, the data of the existing studies 
vary considerably. For example, Ito et al. [54] reported a lethal oral dose of 400 μg/kg b.w.  
Aune et al. [55] reported 880 μg/kg b.w. Tubaro et al. [51] reported 0/5 mice dead at 1000 μg/kg b.w 
and 4/5 dead at 2000 μg/kg b.w., whereas Le Hégarat et al. [56] found inconsistency in the results 
from two independent experiments with the same dose (650 µg/kg b.w.). As of now, data on the oral 
toxicity of OA analogs is scarce, but there are reports that suggest that DTX1 is only slightly less toxic 
when administered orally than when given by i.p. injection [57]. Moreover, according to Ogino et al. [58], 
the lethal oral dose of DTX1 is less than that of OA, with a reported value of 300 μg/kg b.w., suggesting 




higher toxicity. Therefore, the toxicity of these compounds is complex and diverse, where alterations in the 
tight-junction structure of epithelial cells with the addition of PP inhibition are involved in the diarrheic 
process. In this study, we found that DTX1 was able to reduce the TEER, disrupt the Caco-2 
monolayer and pass through the intestinal epithelium. These results could further support that DTX1 is 
more toxic when administered orally than OA and DTX2. 
The toxicity equivalent factors (TEFS) of these compounds also require attention. TEFs 
establishment is a matter of vital importance, especially for the analytical detection of marine and 
freshwater toxins. The control methods require an estimation of the toxic potential of a mixture of 
toxins with different potency to protect consumer’s health [18,59]. To propose the TEFs for the  
OA-group, EFSA assumed that all the toxins share the same biochemical mechanism of action and, 
therefore, were established based only on mice i.p. toxicity. TEFs are defined as the ratio of the toxic 
potency (usually LD50) for each compound compared to the potency of the reference compound (in this 
case, OA). These values are the following: OA = 1; DTX1 = 1; and DTX2 = 0.6 [53]. The lower 
inhibitory potency of DTX2 with respect to OA is comparable to its reduced acute intraperitoneal 
toxicity observed in mice, which allowed for the establishment of a TEF of 0.6 [19]. Nevertheless, 
Smienk et al. [49] have recently reported equal toxicity for DTX2 and OA. 
Human intoxication by DSP is due to seafood consumption. Therefore, the shellfish meat regulation 
level of DSP toxins established by the European Union should be able to protect human health 
regardless of the toxin present in the shellfish sample. In this sense, our study gives new evidence that 
DTX1 oral acute toxicity could be higher than OA or DTX2, due to the increased absorption rate 
through the intestinal tract. Therefore, it constitutes a strong argument for a future revision of the 
actual TEF values for the analogues of the OA-group. 
4. Experimental Section  
4.1. Chemicals and Biological Materials 
Okadaic acid (purity ≥ 98.9%), dinophysistoxin-1 (purity ≥ 98%) and dinophysistoxin-2  
(purity ≥ 98%) are Certified Reference Materials (CRMs) supplied by Laboratorio CIFGA S.A. (Lugo, 
Spain). AlamarBlue
®
 (AB) and anti-occludin mouse monoclonal antibody labeled with Alexa Fluor
®
 
488 were purchased from Invitrogen (Camarillo, CA, USA). Trypan Blue solution 0.4%,  
penicillin-streptomycin solution, staurosporine (STP), Triton-X 100 and bovine serum albumin (BSA) 
were from Sigma-Aldrich (St. Louis, MO, USA). The Annexin V-FITC Apoptosis Detection Kit was 
obtained from Immunostep (Salamanca, Spain). HAM’s F-12 with stable glutamine medium, Eagle’s 
Minimum Essential Medium (EMEM), fetal bovine serum (FBS), gold and 18-mm Aclar coverslips 
were purchased from PAA (Pasching, Austria). Sodium butyrate (NaBT) was purchased from Fluka 
(Steinheim, Germany). Formaldehyde 16% was from Electron Microscopy Sciences (Hatfield, PA, 
USA). Costar 96-well assay plates with a clear bottom and tissue culture-treated surface were from 
Corning Inc. (New York, NY, USA), Falcon Multiwell 12-well polystyrene plates were from Becton 
Dickinson (Le Port de Claix, France). 12-well Milicell hanging culture inserts with a 0.4 μm pore size 
polyethylene terephthalate (PET) membrane were from Millipore Corporation (Billerica, MA, USA). 
Eight-well Nunclon plates were from Nalge Nunc International (New York, NY, USA). All other 




chemicals were reagent grade and purchased from Sigma-Aldrich (Madrid, Spain) and Panreac 
(Barcelona, Spain). Phosphate buffered saline solution (PBS) was 137 mM NaCl, 8.2 mM Na2HPO4, 
1.5 mM KH2PO4, and 3.2 mM KCl, pH 7.4.  
4.2. Cell Lines 
The Caco-2 cell line, which is derived from a human colon adenocarcinoma (ATCC N°: HTB-37), was 
routinely cultured in Eagle’s Minimum Essential Medium with Earle’s salts (EMEM) supplemented with  
2 mM L-glutamine complemented with 10% fetal bovine serum (FBS), 1% non-essential amino acids 
(NEA) and 0.5% penicillin/streptomycin solution. The cells were grown in 75 cm
2
 tissue flasks 
incubated in a humidified atmosphere containing constant 5% CO2 at 37 °C. The culture medium was 
renewed every 2–3 days, and cells were sub-cultured by detaching them with trypsin-EDTA once  
per week. 
4.3. Metabolic Activity Assay 
The viability of the Caco-2 cells was measured by Alamar Blue assay, as previously described [60]. 
Briefly, the Caco-2 cells were seeded onto 96-well plates at an initial concentration of 25,000 cells/mL 
and cultured until differentiation (21 days) with medium renewal every 2–3 days. Subsequently, cells 
were treated with increasing concentrations of OA, DTX1, DTX2 and Triton X-100 in the presence of 
AlamarBlue; then, fluorescence was measured at 6, 8, 10, 12, 24, 48 and 72 hours of incubation using 
a FL600 Microplate Fluorescence Reader from BioTek (Winooski, VT, USA) at an excitation 
wavelength of 530 nm and an emission wavelength of 590 nm. Control cells were considered as having 
100% viability, and the results are expressed as the percentage of the fluorescence of treated cells 
versus the fluorescence of control ones. 
4.4. Apoptosis Detection Assay with Annexin V-FITC 
To visualize apoptosis by confocal microscopy in the toxin-treated Caco-2 monolayers, an apoptosis 
detection kit containing annexin V conjugated with FITC from Immunostep (Salamanca, Spain) was used.  
Caco-2 cells were seeded on glass coverslips at an initial concentration of 65 × 10
3
 cells/mL and 
cultured for 21 days until differentiation with medium renewal each 2–3 days. On the 21st day, the cell 
medium was removed, and the monolayers were treated for 24 h with toxins: OA, DTX1, DTX2, 
vehicle and positive controls of apoptosis and cellular death (staurosporine (STP), sodium butyrate 
(NaBT) and Triton-X 100). Immediately after the 24 h of incubation, the medium was removed, and 
the cells were rinsed 3 times with PBS just before the addition of annexin V-FITC in a proportion of 
1:100 diluted in the provided binding buffer. After 15 min of incubation in the dark at room 
temperature, the cells were rinsed again 3 times with PBS and fixed using paraformaldehyde 2% for  
15 min at 4 °C. Finally, another 3 washes with PBS were required prior to mounting the coverslips 
over microscope glass slides with 10 μL of PBS/Glycerol (1:1) and sealing the edges with nail varnish. 
Confocal imaging was then carried out with a 40× oil immersion objective of a Nikon Eclipse  
TE2000-E inverted microscope attached to the C1 laser confocal system and EZ-C1 V.2.20 software 




(Nikon Instruments Europe B.V., Amstelveen, Netherlands). An argon laser was used to excite the 
annexin V-FITC conjugated protein (λ excitation = 488 nM, λ emission = 530 nM). 
4.5. Trans Epithelial Electric Resistance Measurement 
Trans epithelial electric resistance (TEER) was measured across differentiated Caco-2 monolayers, 
as previously described [60]. The measurements were performed before the treatment with OA, DTX1 
and DTX2 (controls), and after each of the incubation times established: 3, 6, 12 and 24 h. Only inserts 
with TEER higher than 300 Ωcm
2
 before the addition of the toxin were used for further testing.  
4.6. Confocal Microscopy Imaging for Visualizing Occludin 
Alexa Fluor
®
 488-labeled anti-occludin mouse monoclonal antibody from Invitrogen (Camarillo, 
CA, USA) was used for visualizing occludin, as previously described [60].  
Briefly, differentiated Caco-2 monolayers were treated with OA, DTX1, DTX2, vehicle and 
positive controls of apoptosis and cellular death: staurosporine (STP), sodium butyrate (NaBT) and 
Triton-X 100. Immediately after treatments, the cells were fixed and incubated with the anti-occludin 
antibody. Each experimental condition was performed in duplicate. Confocal imaging was then carried 
out with a 40× oil immersion objective of a Nikon Eclipse TE2000-E inverted microscope attached to 
the C1 laser confocal system and EZ-C1 V.2.20 software (Nikon Instruments Europe B.V., 
Amstelveen, Netherlands). An Argon laser was used to excite the Alexa Fluor 488 conjugated antibody. 
4.7. Permeability Assay 
The permeability assay was carried out as previously described [60]. During the assays, cell 
monolayer integrity was evaluated by measuring TEER at the start and end of the experiment. Once 
the incubation with the toxins (OA, DTX1 and DTX2) finished (after 3, 6, 12 or 24 h), the medium 
was collected from both the insert (donor compartment/apical side of the monolayer) and the well 
(receiver compartment/basolateral side of the monolayer) for toxin quantification purposes. Previously, 
we confirmed that the toxins easily flow over the naked inserts. 
4.8. Microsphere-Based Immunoassay for DSPs Detection 
OA, DTX1 and DTX2 samples taken from the inserts/donor compartments and wells/receptor 
compartments where quantified, as previously described by Fraga et al. [61]. In order to consider the 
cross-reactivity of the analyzed derivatives of the okadaic acid, DTX-1 and DTX-2, calibration curves 
were prepared using calibration solutions with CRMs of DTX-1 and DTX-2. Therefore, the 
quantification of DTX-1 and DTX-2 samples collected from permeability assays were quantified 
against their respective calibration curves.  
4.9. Statistical Analysis 
The results were analyzed using the Student’s two-tailed t-test for paired data or the ANOVA 1-way 
test for multiple values, where appropriate. A confidence interval of 95% with a probability level  
p ≤ 0.05 was considered for statistical significance.  




5. Conclusions  
OA, DTX1 and DTX2 did not induce any noticeable cytotoxic effects on differentiated intestinal 
Caco-2 cells at concentrations up to 1 μM for 72 h. However, DTX1 was able to disrupt the monolayer 
integrity at concentrations >100 nM for 12 h and above and to modify occludin distribution between 
adjacent cells. Furthermore, the permeability assay performed revealed a greater intestinal absorption 
of DTX1 when compared to OA or DTX2. These data suggest new evidence that the oral toxicity of 
DTX1 is higher than OA or DTX2.  
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